Agitation in dementia. Gill Livingston

Similar documents
Managing agitation in dementia using non-pharmacological therapies

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

Dementia: Rethinking our approach to behaviour

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4

Neurocognitive Disorders Research to Emerging Therapies

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management

The Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias

Summary of funded Dementia Research Projects

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

Behavioral and Psychological Symptoms of dementia (BPSD)

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Drugs used to relieve behavioural and psychological symptoms in dementia

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Antipsychotic Medications

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?

Pharmacological Treatment of Aggression in the Elderly

Management of Behavioral Problems in Dementia

Effectiveness of START psychological intervention in reducing abuse by dementia family carers: randomized controlled trial

Treatment Options for Bipolar Disorder Contents

This information explains the advice about supporting people with dementia and their carers that is set out in NICE SCIE clinical guideline 42.

The Living well with dementia groups project

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

Recognition and Management of Behavioral Disturbances in Dementia

Community Pharmacy Dementia Audit

Management of the Acutely Agitated Long Term Care Patient

Risks of Antipsychotics use In Dementia

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal

MEDICATIONS IN MANAGING DIFFICULT BEHAVIORS

Sleep & Relaxation. Session 1 Understanding Insomnia Sleep improvement techniques Try a new technique

Non-pharmacological Approaches in Dementia Care. Dr. Anna Fisher

Treatment of behavioral and psychological symptoms of dementia: a systematic review

BEHAVIORAL PROBLEMS IN DEMENTIA

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

MANAGEMENT OF NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA

Delirium. Script. So what are the signs and symptoms you are likely to see in this syndrome?

Aims for todays session

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

PSYCHOTROPIC SOLUTIONS

South London and Maudsley NHS Foundation Trust: FY1819 Q2 Performance in Initiating

Scottish Pilot of the Tailored Activity Programme Progress to date. Jenny Reid AHP Dementia Consultant NHS

Addressing Difficult Behaviors in Dementia

Workshop cases answers

5/17/2017. Conflicts of Interest. Key Takeaways

Psychotropic Medication. Including Role of Gradual Dose Reductions

Management of Behavioral and Psychological Symptoms in People with Dementia Living in Care Homes: A UK Perspective

If you have dementia, you may have some or all of the following symptoms.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

CRITICALLY APPRAISED PAPER (CAP)

GLOSSARY OF GENERAL TERMS

Lancet Commission on Dementia prevention, intervention and care

May 2015 Clinical Nurse Educator Arohanui Hospice

Drugs for behavioural and psychological symptoms in dementia

New Medications in Early Psychosis

After the Liverpool Care Pathway Study. Rules of Thumb for End of Life Care for People with Dementia

Managing challenging behaviours

Dementia care - working together to support complex needs

Dementia Prevention, Intervention and Care

Evaluation and Management of Agitation and Aggression in Dementia Joseph W. Shega, MD National Medical Director

Appendix N: Research recommendations

Interventions for Autism: Translating Research into Practice

Fall Prevention For Older People In Care Homes Julie Whitney 20 th June 2017

Behaviour that Challenges in dementia care: an update of psychological approaches for home and care home settings 1

Preventing delirium while in hospital Tips for family, whānau, and friends who are supporting an older person

The place for treatments of associated neuropsychiatric and other symptoms

Method. NeuRA Paliperidone August 2016

The treatment of bipolar disorder in adults, children and adolescents

CARING FOR PATIENTS WITH DEMENTIA:

Assessment and management of behavioral and psychological symptoms of dementia


Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review

National Audit of Dementia

Supporting people with dementia to live well in London care homes

End of Life Care in Dementia. Sue Atkins Dignity in Care/Dementia/Learning Disabilities Clinical Nurse Specialist

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

How to prevent delirium in nursing home. Dr. Sophie ALLEPAERTS Geriatric department CHU-Liège Belgium

Appendix L: Research recommendations

Please Join Us. International Psychogeriatric Association. Dependency Ratio. Geriatric Psychiatry in the 21st Century: A Global Perspective

Resubmission. Scottish Medicines Consortium

Trial clinici nell anziano: efficacy or effectiveness?

De-escalating Anger and Aggression in Aging adults: Strategies to Make It Work!

Antipsychotics for Dementia Under Control or Over-Prescribed?

Reducing Use of Antipsychotic medications in Long-Term Care Residents with Dementia: Ten Best Practices

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

Prescribing for people with dementia. Carol Paton Chief Pharmacist April 2009

DELIRIUM IN ICU: Prevention and Management. Milind Baldi

Lecture 5 Conducting Interviews and Focus Groups

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director

Appendix K: Evidence review flow charts

Disclosure Information

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

It Takes a Village: Caring for Veterans with Advanced Dementia

DEMENTIA AND MEDICATION

Social Communication in young adults with autism spectrum disorders (ASD) Eniola Lahanmi

OLDER PEOPLE WITH DUAL SENSORY LOSS: MEETING THEIR NEEDS. Nicola Venus-Balgobin

Transcription:

Agitation in dementia Gill Livingston

And some of the team Gianluca Baio Julie Barber Claudia Cooper Briony Dow Paul Higgs Juanita Hoe Gerry Leavey Louise Marston Stephen Morris Rumana Omar Nishma Patel Penny Rapaport Liz Sampson

Funding Acknowledgement: This is independent research commissioned by: UK National Institute for Health Research (NIHR) Health Technology Assessment Programme: HTA 10/43/01 and ESRC/NIHR ES/L001780/1 The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, ESRC, NHS or the Department of Health. The studies are sponsored by UCL. Neither funders nor sponsors had a role in the study design and the collection, analysis, and interpretation of data and the writing of the article.

What I will talk about What is agitation? Why is agitation important in dementia? Drugs? Why not just consider neuropsychiatric symptoms as a whole? What we did. What we found: What works, who for, what length of time and what setting. What doesn t work. What needs more evidence. What it means, why it matters. MARQUE: testing the theory and working out the practice.

What is agitation in dementia? Agitation is inappropriate verbal, vocal or motor activity. Encompasses purposeless activity, shouting out, physical and verbal aggression and wandering. It is behavioural component not solely emotional.

Why is agitation important in dementia? Dementia is common and costly. Most care home residents have dementia, and residential care contributes substantially to the costs of dementia currently $818 billion a year. Agitation is common, persistent and distressing. 80% of those with clinically significant symptoms still symptomatic 6 months later. Agitation leads to: Excess cost -care breakdown and care home admission. Decreased quality of life. Agitation affects family relationships adversely.

Why we don t just use drugs.

Antipsychotics Increase cognitive decline; EPSE; mortality. Limited efficacy. Evidence that haloperidol, risperidone, aripiprazole and olanzapine work sometimes. Quetiapine does not. Atypicals increase mortality 1.5-1.7 x in first 90 days. Haloperidol increases 1.5 x more

Other drugs - limited efficacy and risks ++ Citalopram - increases QT interval and decreases cognition Benzodiazepines increase cognitive decline. Cholinesterase inhibitors and memantine ineffective. Analgesics - one RCT (non-placebo controlled) improved agitation in people with dementia. Effect size comparable to antipsychotics Preliminary evidence with carbamazepine mirtazepine, Valproate ineffective

Dextromethorphan-Quinidine on Agitation in AD Preliminary 10-week phase 2 RCT in AD Efficacious (NPI 1.5; 95% CI, 2.3 to 0.7; P<.001) Generally well tolerated. low-affinity, uncompetitive N-methyl-d-aspartate receptor antagonist, σ1 receptor agonist, serotonin and norepinephrine reuptake inhibitor, and neuronal nicotinic α3β4 receptor antagonist. 7.9 % SAE vs 4.7% placebo Cummings JE, Lyketsos,C. Peskind E et aljama. 2015;314(12):1242-1254. doi:10.1001/jama.2015.10214.

Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. Gill Livingston, Lynsey Kelly, Elanor Lewis- Holmes, Gianluca Baio, Stephen Morris, Nishma Patel, Rumana Z. Omar, Cornelius Katona, Claudia Cooper DOI: 10.1192/bjp.bp.113.141119 Published 1 December 2014

What we did 1. Systematically review nonpharmacological interventions 2. Consider: 1. How long it worked for 2. Severity of agitation 3. Setting in which it works

Analysis Calculated standardised effect sizes (SES;95% CI) to compare studies using a common effect measure. used data from the last time point to estimate the SES We recalculated results for studies not directly comparing intervention and control groups Meta-analysis impossible as required homogenous interventions with same outcome measure.

Interventions which worked - in some circumstances Activities Music therapy to a protocol Sensory interventions Supervised person centred care Supervised communication skills Dementia mapping

Activities Five included RCTs implemented group activities in care homes (e.g. cooking, storytelling) symptomatic agitation (SES range =0.2 to 1.05) while in place. Individualising activities did not cause significant additional reductions in agitation. There is no evidence for those who are severely agitated or who are not resident in care homes.

Music therapy by protocol Music therapist warm up with a well known song, listening to, then joining in with music In care homes this overall agitation immediately. SES 0.5-0.9 There is no evidence for people with severe agitation or outside care homes No evidence it works over long term

Sensory interventions Sensory interventions e.g. massage, massage and music, multisensory intervention. symptomatic agitation, and clinically significant agitation, during the intervention. Therapeutic touch (healing based touch focusing on person as a whole) was not superior to usual treatment. No evidence about long term or outside care homes.

Person centred care; communication skills; dementia care mapping Six RCTs in care homes to change paid carer s perspective with supervision Communication and thoughts, to see and treat people with dementia as individuals vs task focussed. PCC and CS symptomatic and severe agitation, immediately. SES= 0.3-1.8 and 0.2-2.2 and up to six months. Dementia care mapping severe agitation, SES= 1.4, immediately and 1.5 and four months afterwards.

Interventions which do not work Light therapy Aromatherapy Training family carers in behavioural and cognitive interventions

Light therapy Light therapy hypothesised to reduce agitation through manipulation of the disrupted circadian rhythms of dementia, by 30-60mins of daily bright light exposure. Three large RCTs showed light therapy increases agitation. The SES was from 0.2 for improvement to 4.0 for worsening symptoms.

Aromatherapy Blinded assessments found ineffective. Results of non-blinded studies mixed. Aromatherapy not been shown to work for agitation

Training family caregivers in behavioural management or CBT for people with dementia living at home Three RCTs Ineffective (harmful) for severe agitation No immediate or long term effect to decrease agitation symptoms

Agitation Sensory interventions, activities and music therapy by protocol reduce agitation and decrease symptomatic agitation in care homes while they are happening. No evidence for those who are severely agitated.

Communication Training paid caregivers in communication or person centred care skills or dementia care mapping with supervision Effective for symptomatic and severe agitation, during the intervention and for six months. Some evidence that it helps prevent emergent agitation. The standardised effect sizes suggest they are similarly efficacious.

What is agitation in dementia? Our hypothesis Way of communicating feeling bad Pain, constipation, thirst, boredom, lack of touch, loneliness, discomfort Brain changes Communication and listening plus sensory activity done well may make the difference Clearly best to prevent Need effectiveness and cost effectiveness RCT Lots more work at home, where most people are

UK cost of agitation in dementia Adjusted annual cost/person with AD with significant agitation = 33 075 Vs 28 983 Excess cost associated with agitation = 4091/person/year. So.agitation accounts for 12% of health and social care costs of AD each year. The expected excess cost associated with agitation in people with AD is therefore 2.0 billion a year. Potential to save money ++ with effective interventions.

What is MARQUE? The MARQUE project: Managing Agitation and Raising QUality of life in dementia Funded by ESRC/NIHR as part of the PM's 'Challenge on Dementia' Aims to increase knowledge about agitation in dementia in all settings

MARQUE as Multiple Streams Stream 1 - Theoretical understanding of personhood and agitation. Stream 2 - Longitudinal study of agitation, quality of life and coping strategies in care homes. Stream 3 - Development and testing of intervention in care homes Stream 4 - Qualitative exploration of agitation and family carers coping at home. Stream 5 - End of life and agitation: Ethnographic study of people with dementia, families and paid carers. Stream 6 - Pilot intervention at end of life.

Stream 1 Conceptualisation of personhood Essential components of personhood e.g. agency, consciousness, identity, rationality and reflexivity? Is it a moral absolute of all human beings? Is it a matter of degree? Kitwood does not distinguish between the metaphysics of personal identity and the moral standing of persons.

How are we doing - Stream 2? Really well! We have recruited 97 care home clusters nationally We currently have 4111 people consented to the study: 1602 staff 1443 residents 1066 relatives

Testing our model - Agitation level in homes Agitation associates Less family visits More dysfunctional coping in staff Staff numbers Less activities Environment (TESS) Possible confounders: Age; severity of dementia; type of home Agitation leads to higher care costs.

preliminary analysis 84 care homes: median age residents age 85; ¾ female 45 have a mean score of CMAI of >45 Median ranges 31-77 Commonest behaviour: general restlessness Least common: eating or drinking inappropriate substances Significant difference between care homes of nearly each individual type of agitated behaviour

What are we doing next? Stream 3 Randomised control study with 20 care homes We have developed a supervised manual for staff training Currently finalising the manuals and training Research Assistants to pilot the study 20

Development Knowledge-systematic review Form- START manual (homework, information with task, relaxation) Content - using qualitative interviews with staff and using their words Make it concrete games, DICE

MARQUE Session 1: Getting to know the person with dementia Session 2: Pleasant Events Session 3: Improving Communication Session 4: Understanding Agitation Session 5: Practical Responses and Making a Plan Session 6: What works? Using skills and strategies in the future

Each session will include A recap on the previous session A chance for you to discuss the last session and how you got on with the exercises. A discussion about a new topic for that session. A practical exercise for you to try out between sessions A new way of reducing stress The residents, you see, they're the same as you are. They were mums, you know, they were going to college, they studied, they were driving, they're like us, today they are old, tomorrow I'm old. (Nurse)

Stream 4 - At home Qualitative interviews Carers helped by: Someone to take over care immediately Relaxation Keeping own interests and friends Seeking help immediately Not about reducing agitation but coping with it

Stream 5 - Agitation and dementia in hospitals One ward: nurses not responding call bells out of reach data e.g. hourly checks fabricated One ward staff respond Sometimes soothing Sometimes shouting More response to basic care needs Lack of recognition of pain even when patient said it. Some think people with dementia can t feel pain

What impact do we want? To make managing agitation as much a part of care as providing food, shelter and hygiene to improve living and dying with dementia.